Physician profile
Matthew Joseph
NPI 1013273044
$5,418.11
in general payments reported to CMS, 2019-2025
42 companies · $2,013 in 2025
The $2,013 reported for 2025 was more than what 97% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,146 · 2020: $858 · 2021: $354 · 2022: $353 · 2023: $244 · 2024: $450 · 2025: $2,013.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,683 · Food and Beverage: $1,025.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,682.69 |
| Food and Beverage | $1,024.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,705.49 | 2025 | Trodelvy |
| Janssen Pharmaceuticals, INC | $541.89 | 2019-2024 | Xarelto |
| Glaxosmithkline, LLC. | $261.98 | 2020-2024 | Ojjaara |
| Astrazeneca Pharmaceuticals LP | $261.62 | 2019-2025 | Imfinzi |
| Pfizer INC. | $241.89 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $203.74 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $200.78 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $189.09 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $181.09 | 2019-2024 | Xifaxan |
| Janssen Biotech, INC. | $160.53 | 2019-2025 | Darzalex, Akeega, Erleada |
| Intuitive Surgical, INC. | $154.56 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $107.51 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.60 | 2019-2025 | Gilotrif |
| Aveo Pharmaceuticals, INC. | $81.10 | 2024-2025 | |
| Daiichi Sankyo INC. | $79.78 | 2022-2025 | Enhertu |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.